Biosynthesis Of The Immunosuppressant (-)-Fr901483

Zhuan Zhang,Yui Tamura,Mancheng Tang,Tianzhang Qiao,Michio Sato,Yoshihiro Otsu,Satoshi Sasamura,Masatoshi Taniguchi,Kenji Watanabe,Yi Tang
DOI: https://doi.org/10.1021/jacs.0c12352
IF: 15
2021-01-01
Journal of the American Chemical Society
Abstract:We report characterization of the biosynthetic pathway of the potent immunosuppressant (-)-FR901483 (1) through heterologous expression and enzymatic assays. The biosynthetic logic to form the azatricyclic alkaloid is consistent with those proposed in biomimetic syntheses and involves aza-spiro annulation of dityrosyl-piperazine to form a ketoaldehyde intermediate, followed by regioselective aldol condensation, stereoselective ketoreduction, and phosphorylation. A possible target of 1 is proposed based on the biosynthetic studies.
What problem does this paper attempt to address?